Moreover, MCP-1 has been indicated as an independent diagnostic marker in subjects with a history of acute coronary syndrome since higher MCP-1 levels were related to a higher risk of death, myocardial infarction and heart failure [11,12]. This evidence concerns the gene CCL2 and myocardial infarction.